We only have this paper's title and publication details.
Read it at the sourceExperimental findings reveal that anti-fibulin-3 treatment decreases immunosuppression in glioblastoma, suggesting enhanced immune responses.
Figure S7. Anti-fibulin-3 treatment decreases immunosuppression in GBM.
No takes yet. Share an insight, caveat, or question.
Kundu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: